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Abstract
ABSTRACT
Conjunctival chemosis is a common ophthalmic finding that presents with 
a wide range of severities, symptoms, signs, and underlying etiologies. Al-
though most cases of conjunctival chemosis are ocular in nature (allergy, 
infection, irritation), atypical presentations, such as dusky conjunctival hue, 
corkscrew conjunctival veins, and periorbital edema, should prompt further 
investigation for a systemic cause. In atypical cases, a review of the patient’s 
medical history and medications, physical examination of the patient’s heart 
and lungs, and determination of the patient’s vitals (i.e., blood pressure, pulse, 
weight) are crucial for identifying a potential systemic source. This article re-
views systemic causes of conjunctival chemosis and provides case examples 
to demonstrate evaluative and management techniques for optometrists to 
make a distinction between ocular and systemic conjunctival chemosis. 
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INTRODUCTION
Conjunctival chemosis, which is edema of the conjunctiva and the caruncle, 
is a common ophthalmic complication that presents with a wide range of se-
verities, symptoms, signs, and underlying etiologies. Common clinical char-
acteristics include diffuse translucent swelling of the bulbar conjunctiva and 
caruncle, folds or rugae of the conjunctival cul-de-sac, and associated tarsal 
conjunctival papillae.1,2 Atypical features may include conjunctival conges-
tion and dusky colored chemosis. To determine its etiology, it is crucial to 
use the ocular history, symptoms and slit lamp biomicroscopy signs (chemo-
sis severity and color, and accompanying ocular signs). Although most cases 
of conjunctival chemosis are ocular in nature (allergy, infection, irritation), 
atypical presentations should prompt further investigation for a systemic 
cause. In atypical cases, a review of the patient’s medical history and medi-
cations, physical examination of the patient’s heart and lungs, and determi-
nation of the patient’s vitals (i.e., blood pressure, pulse, weight) are crucial 
for identifying a potential systemic source. Systemic diseases that manifest 
conjunctival chemosis can be serious and even life-threatening, highlighting 
the importance of identifying this association. This article reviews systemic 
causes of conjunctival chemosis and provides case examples to demonstrate 
evaluative and management techniques for optometrists to distinguish be-
tween ocular and systemically derived conjunctival chemosis. 
CASE REPORTS
Case 1: 
A 59-year-old African-American male reported for a routine eye exam with 
stable vision and good comfort OU. The patient’s ocular history was per-
tinent for vitreous degeneration OU, blepharitis OU, and mild hyperten-
sive retinopathy OU. He had no history of ocular trauma or surgery, recent 
exposure to allergens, or history of seasonal allergies. His medical history 
was pertinent for benign essential hypertension, atrial fibrillation without 
recurrence following treatment with direct current cardioversion surgery, 
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aneurysm of ascending aorta, bipolar affective disorder, sickle cell trait, displacement of intervertebral disc, adrenal 
cortical adenoma, chronic back pain, and polysubstance abuse (alcohol, marijuana, cocaine). 
His medications included albuterol oral inhaler, aspirin 81mg, carvedilol, divalproex, ibuprofen, omeprazole, silde-
nafil citrate, and tamsulosin. Allergies included haloperidol, lurasidone, and peanuts. 
Ocular examination revealed corrected visual acuities of 20/20 OD and OS. Pupils, extraocular motility, cover test and 
confrontation fields were normal in both eyes. Gross physical examination revealed 1+ edema of the superior and infe-
rior orbital rim OU, venous engorgement of the right jugular vein, dyspnea, dry and non-productive cough, and pitting 
edema of the right and left ankles. Elevated blood pressure (160/105 mmHg) and normal pulse (84 beats per minute) 
were noted. Slit lamp biomicroscopy revealed eyelid collarettes. The conjunctiva revealed 3+ dusky chemosis from 6 to 
9 o’clock OD and 1+ dusky pink chemosis from 3 to 4 o’clock OS (Figure 1). The cornea had arcus OU, with a tear break-
up time of 10 seconds. The crystalline lens showed 1+ cortical opacities OU. Intraocular pressures by applanation were 
16 mmHg OD and 14 mmHg OS at 9:55 A.M. Dilated fundus examination was significant for posterior vitreous detach-
ment OU and tortuous retinal blood vessels consistent with hypertensive retinopathy OU.
Figure 1: Case 1 – Diffuse conjunctival chemosis secondary to hypervolemia from acute decompensated heart failure with 
prolapse of bulbar conjunctiva over the lid margin
The patient was diagnosed with atypical conjunctival chemosis. Due to his cardiac risk factors (hypertension, atrial fibril-
lation, tobacco use, former alcohol and illicit drug abuse), ocular signs (dusky pink conjunctival chemosis OU, periorbital 
edema OU), systemic signs (venous engorgement of the right jugular vein and anasarca of the right and left ankles), and 
symptoms (dyspnea, dry and non-productive cough), the patient was suspected to have chemosis secondary to hypervol-
emia due to acute decompensated heart failure. The patient was sent to the emergency department for further medical 
evaluation and blood work, to include renal and liver panels and cardiac biomarkers (B-type natriuretic peptide, tropo-
nin-I, and creatinine kinase). The results of the renal and liver panels were normal; however, elevated B-type natriuretic 
peptide levels (2,277 pg/ml) and troponin-I (0.14 ng/ml) confirmed a diagnosis of acute decompensated heart failure 
by cardiology, and the patient was admitted to the hospital for further evaluation and treatment. After his blood pres-
sure was stabilized (135/90 mmHg) using intravenous hydralazine, furosemide, and acetaminophen, he was discharged 
from the hospital with newly prescribed atorvastatin calcium, lisinopril, and spironolactone. A cardiovascular work-up 
one week later, which included coronary angiogram and trans-thoracic echocardiogram, confirmed right- and left-sided 
heart failure, which the patient opted to medically manage with oral anti-coagulant and an anti-arrhythmic. One month 
later, cardiovascular stability and resolved conjunctival chemosis were confirmed by cardiology and optometry. 
Case 2: 
A 67-year-old African-American male presented for his yearly diabetic eye exam with stable vision OU. He reported 
itchy skin and painless left eye swelling since starting daily amlodipine 5 mg ten months previously for hyperten-
sion. His ocular history included meibomian gland dysfunction, dry eye syndrome, mild hypertensive retinopathy 
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OU, type 2 diabetes mellitus without ophthalmic complications OU, and mild cataracts OU. He had no history of 
ocular trauma or surgery, and no recent exposure to allergens. His medical history was pertinent for hypertension, 
hyperlipidemia, type 2 diabetes mellitus with neuropathy, obesity, sleep apnea, male erectile disorder, benign hy-
pertrophy of the prostate, spinal stenosis of the lumbar region, osteoarthritis, and gastroesophageal reflux disease. 
His medications included artificial tears, fosinopril, terazosin, simvastatin, amlodipine besylate, omeprazole, varde-
nafil, aspirin, tramadol, metformin, hydrochlorothiazide, and cholecalciferol (vit D3). 
Ocular examination revealed corrected visual acuities of 20/20 OD and OS. Pupils, extraocular motility, cover test 
and confrontation fields were normal in both eyes. Gross physical examination was remarkable for peripheral pit-
ting edema of both ankles. Mildly elevated blood pressure (162 /91 mmHg) and normal pulse (75 beats per min-
ute) were noted. Slit lamp biomicroscopy of the eyelids revealed turbid expressions of the meibomian glands OU, 
conjunctival racial melanosis OU, nasal pterygium OU, and mild temporal conjunctival chalasis OD. The left eye 
revealed 3+ translucent bulbar conjunctival chemosis extending from the limbus to the fornix with sparing of the 
superior quadrant OS (Figure 2). The patient confirmed habitually sleeping in a decubitus position on his left side. 
The cornea, anterior chamber, iris, and lens were unremarkable OU. Tear break-up time was 7 seconds. Intraocular 
pressures by applanation were 15 mmHg OD and 16 mmHg OS. Dilated fundus examination revealed tortuous reti-
nal blood vessels consistent with hypertensive retinopathy OU.
Figure 2: Case 2 – Diffuse conjunctival chemosis secondary to amlodipine allergy with translucent conjunctival edema and 
caruncle swelling
The patient was advised to continue with warm compresses b.i.d. OU and artificial tears t.i.d. OU. He was told that his 
conjunctival chemosis required a non-urgent consult to his primary care physician for suspected amlodipine allergy, 
especially after the patient confirmed itchy skin. The patient was advised to continue amlodipine, as a hypersensitivity 
reaction to this medication was a diagnosis of exclusion. The patient was also referred to cardiology for evaluation, 
due to his cardiac risk factors (diabetes, hypertension, hyperlipidemia, and sleep apnea). Cardiology evaluation with 
coronary angiogram, trans-thoracic echocardiogram, renal and liver panels, and cardiac biomarkers (B-type natri-
uretic peptide, troponin-I, and creatinine kinase) revealed ischemic heart disease without acute decompensated heart 
failure. Amlodipine allergy was confirmed due to cardiopulmonary stability and non-pitting anasarca of the ankles. 
Amlodipine was discontinued and carvedilol was initiated in its place. At the one-month follow-up cardiology and eye 
examination, the patient’s blood pressure was well-controlled and the conjunctival chemosis was resolved.
DISCUSSION
Anatomy
During episodes of conjunctival chemosis, the bulbar conjunctiva is primarily affected. The bulbar conjunctiva is a 
loosely connected, semitransparent mucous membrane overlying the anterior globe between the superior and infe-
rior fornices and extending to the corneal limbus.3 Within the stromal layers of the bulbar conjunctiva lies a matrix of 
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lymphatic vessels (sub-mucosa) and blood vessels (deeper sub-mucosa) where extracellular fluids may accumulate. 
This space of loose attachment between the bulbar conjunctiva and underlying Tenon’s layer and sclera is where fluid 
build-up occurs during episodes of inflammatory, infectious, or vascular events.4 Since the palpebral conjunctiva is 
more tightly adherent to the tarsus, edema is less pronounced at this level and may simply present with papillae. 
Ocular History
A thorough patient ocular history can be revelatory for patients who present with conjunctival chemosis since most 
cases have an underlying ocular etiology with a distinct mechanism of action (Table 1).2,5-19 Common ocular etiolo-
gies include foreign body (conjunctival, corneal, eyelid), mechanical trauma (eye rubbing, blunt-force injury, tri-
chiasis, tarsal plate concretion cysts, papillae, or follicles), acute glaucoma, ocular infection (conjunctivitis, keratitis, 
scleritis, endophthalmitis), or orbital infection (orbital cellulitis), allergy (conjunctivitis) and ocular inflammatory 
disorders (episcleritis, scleritis, uveitis).12-15,18 
Adverse toxic effects from ophthalmic drugs, termed medicamentosa or toxic keratoconjunctivitis,20 may also pro-
duce conjunctival chemosis. Numerous ophthalmic medications have been implicated in this type of reaction (Table 
2).16-18,21-27 Specific patterns of corneal, eyelid, and other conjunctival findings (follicular papillary reactions, sym-
blepharon and/or fornix shortening, scarring, periocular skin hyperemia/induration/scaling) may help to confirm 
this etiology (Table 3).16,17,21,28 Bulbar conjunctival injection may be greater inferiorly than superiorly, and corneal 
epitheliopathy may be greatest inferonasally because of increased contact time with the pharmaceutical.28,29 Clinical 
signs usually take several weeks to develop18 and unilateral or asymmetric conjunctival chemosis is not uncommon 
with medicamentosa or other toxic exposures.17 
Slit Lamp Biomicroscopy Clinical Signs 
Detailed slit lamp biomicroscopy is crucial for diagnosing and managing conjunctival chemosis.1,2 The primary charac-
teristics of conjunctival edema include translucent swelling of the bulbar conjunctiva, folds or rugae of the cul-de-sac, 
and associated tarsal papillae.1 Caruncular edema presents as a swollen hyperemic caruncle, which at times can appear 
dry. Mild bulbar conjunctival chemosis is more likely to present as small redundant folds of conjunctiva extending past 
the mucocutaneous junction of the lower eyelid, while severe cases reveal prolapsed conjunctiva across the lower eyelid.2 
Although conjunctival chemosis may present unilaterally, bilateral, and symmetric involvement could indicate systemic 
etiology. The jelly-like conjunctival appearance is either pale and colorless, or dusky red.1 Cases that are pale and colorless 
are usually due to non-venous congestion-related etiologies1, as seen in ocular trauma, ocular infections and inflamma-
tory conditions, chemical burns and contact hypersensitivity reactions. Blunt force and chemical ocular trauma are both 
ocular emergencies that require ophthalmology consultation if conjunctival chemosis is suspected to be accompanied by 
scleral rupture or alkaline chemical burns.5 Conjunctival chemosis that takes on a dusky red appearance and is accom-
panied by prominent conjunctival venous dilation is more likely to originate from a systemic venous blockage or conges-
tion etiology.1 Conjunctival chemosis accompanied by corkscrew conjunctival veins suggests the possibility of retrograde 
venous flow, termed arterialization. Ninety percent of patients with arterialization of the conjunctival veins have carotid 
cavernous sinus fistulas.30 Eyelids should be everted during slit lamp biomicroscopy to rule out a mechanical or traumatic 
etiology (foreign bodies, trichiasis, palpebral conjunctival and tarsal plate cysts, papillae, or follicles). It can be helpful to 
test corneal sensitivities if herpetic eye disease and neurotrophic keratopathy are suspected. 
Symptomatology
In the absence of an underlying ocular etiology for conjunctival chemosis, a comprehensive medical history, a re-
view of the symptomology and identification of any systemic hypersensitivity reactions to drugs, foods, chemi-
cal exposures, contact lens solution, cosmetics (skin and hair products), and illicit drugs can help determine if a 
systemic etiology exists (Table 4a-e6,18,30-52 and Table 52,6,18,33,40,42,49,53-58).The acuteness or chronicity of symptoms can 
help differentiate a localized ocular versus systemic cause of conjunctival chemosis. An acute onset of conjunctival 
chemosis is usually indicative of a hypersensitivity response (Table 2).2,16-18,21-27A subacute or chronic onset of con-
junctival chemosis may have numerous etiologies , including localized ocular tissue responses (thyroid eye disease, 
chronic allergic conjunctivitis, ocular or eyelid surgery, trauma), increased systemic vascular permeability (allergic 
conditions, infections including meningitis, vasculitis), increased venous pressure (superior vena cava syndrome, 
heart failure), and decreased plasma oncotic pressure (nephrotic syndrome, hepatic disease).2,18,59 
SYSTEMIC ETIOLOGIES OF CONJUNCTIVAL CHEMOSIS
Hypersensitivity Reactions
Numerous systemic medications have been implicated in hypersensitivity-related conjunctival chemosis 
(Table 2).16-18,21-27 Although drug-induced hypersensitivity reactions account for 36.2% of anaphylaxis, food allergies 
remain the most common cause (49.7%) and recent food consumption should be investigated.33 Ocular signs may 
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have concurrent dermatological signs and symptoms. Skin reactions (intense itching, flushing, eye or lip-tongue-
uvula edema) and urticaria (rash sometimes accompanied by superficial dermal edema) are the most common pre-
senting hypersensitivity symptoms, with a higher prevalence with food (90.9% and 86.9%, respectively) than with 
drugs (69.4% and 66.7%, respectively).33 Although dyspnea presents equally in each group, respiratory symptoms 
(wheezing, stridor, hypoxemia) are more common with food allergies, while cardiovascular symptoms (syncope, 
hypotension, urinary incontinence, chest discomfort) are more common with drug allergies.33 
Non-hypersensitivity Reactions
Systemic etiologies of conjunctival chemosis not attributable to hypersensitivity reactions include cavernous sinus 
disease (carotid cavernous sinus fistula, carotid cavernous sinus thrombosis), thyroid disease (hyperthyroidism, 
Grave’s disease), superior vena cava syndrome, and hypervolemia (with its various underlying systemic conditions) 
(Table 4b-e).6,18,30-52
Cavernous Sinus Disease
Cavernous sinus disease (carotid cavernous sinus fistula and carotid cavernous sinus thrombosis) may present with 
conjunctival chemosis, in addition to numerous cranial nerve deficits. 
Carotid cavernous sinus fistula is an anomalous connection between the venous system of the cavernous sinus and 
the internal carotid artery or its meningeal branches, or meningeal branches of the external carotid artery.60 Con-
junctival chemosis will present in 42% of patients with a carotid cavernous sinus fistula, and is characterized by the 
pathognomonic finding of corkscrew arterialization of the conjunctival veins (93%).30 Additional clinical signs that 
occur as a result of the congestive effects of abnormal blood flow from within the cavernous sinus include proptosis 
(84%), decreased visual acuity (43%), cranial nerve palsy (52%), and bruit (28%).30 
Carotid cavernous sinus thrombosis is an aseptic (surgery, trauma) or septic (sinusitis, otitis, odontogenic, facial 
faruncles, erysipelas) blood clot (thrombus or embolism) that travels to the cavernous sinus.61 Acute signs present-
ing from congestion or blockage of the venous system include proptosis, ptosis, and chemosis.32 These patients have 
a higher likelihood of a cranial nerve palsy than carotid cavernous sinus fistula patients (80-100% versus 52%), and 
the abducens nerve is affected most often (73%).32 However, key differentiating symptoms of periorbital edema, 
headache, lethargy, and altered sensorium (50-80%) are typically observed with a cavernous sinus thrombosis.32 
Hyperthyroidism
Hyperthyroidism can result in conjunctival chemosis secondary to fluid accumulation of glycosaminoglycans in 
connective tissue, resulting in edema and inflammation of the extraocular muscles, orbital connective tissue and 
fat, increased orbital volume, and decreased venous and lymphatic drainage.49,53 Investigations for an associated hy-
perthyroid condition should account for the patient’s age. Younger patients (<50 years) are classically more symp-
tomatic than older patients (> 70 years), but have the same core symptoms as their elders: tachycardia (96% versus 
71%), fatigue (84% versus 56%), and weight loss (51% versus 50%).33,34 Additionally, younger patients are more likely 
to have other symptoms, including neurological symptoms, dyspnea, and polydipsia (Table 4).6,18,30-52 Twenty-five to 
forty percent of thyroid patients have thyroid orbitopathy,35,36 with common symptoms of pain (30%), lacrimation 
(20.8%), diplopia at initial presentation (16.6%), photophobia (15.8%), and blurred vision (7.5%).37 
Superior Vena Cava Syndrome
Obstruction or compression of the superior vena cava, a large vein that carries deoxygenated blood from the upper 
extremities, head, neck, and thorax to the right atrium, can  lead to decreased venous drainage, termed superior 
vena cava syndrome.40 Its most common sign is facial or neck swelling (82%)40 that is aggravated in the horizontal 
position. Patients may also complain of upper-extremity swelling (68%), dyspnea (66%), and cough (50%).40 Sixty 
percent of superior vena cava syndrome cases are due to malignant etiologies, specifically bronchogenic carcinoma 
(small cell and non-small cell lung cancer) (46%), lymphoma (8%) and germ cell tumors (8%).40 Superior vena cava 
syndrome can also result from other etiologies in 40% of cases, such as medical devices (intravascular devices, 
dialysis catheters, pacemaker wire, Hickman catheter), and fibrosing mediastinitis (secondary to lymphoma, histo-
plasmosis, tuberculosis, syphilitic aortic aneurysm).40 Seventy-one percent of these benign etiologies are secondary 
to intravascular medical devices, as the most common cause.40
Hypervolemia
Hypervolemia, also known as fluid overload syndrome, is a condition where there is excessive fluid in the blood, 
primarily consisting of blood plasma, salt and water. Conditions associated with hypervolemia include heart failure, 
nephrotic syndrome, and liver disease, each of which has its own differentiating signs and symptoms. 
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In the evaluation of hypervolemic heart failure patients, the physical examination has greater specificity and less 
sensitivity than the patient history.41 The most common general symptom is dyspnea (87-93%), and exertional dys-
pnea is the most common type (86-97%).41 Other more prevalent symptoms include edema (35-70%), jugular vein 
distension (5-54%), rales (25-45%) and gallop heart beat (1-26%).41 
Nephrotic syndrome is a kidney disorder that is often idiopathic and characterized by peripheral edema, heavy 
proteinuria, hypoalbuminemia, and hyperlipidemia.42-44 Type 2 diabetes mellitus and systemic lupus erythemato-
sus are the conditions that are most commonly associated with systemic causes of nephrotic syndrome.43,44 Clinical 
signs include periorbital edema that is worse in the morning, end-of-day pitting edema of the legs,42 edema of the 
abdomen and genitals,42 foamy urine secondary to proteinuria,42 whitening of fingernails with or without white 
bands (Muercke’s lines) secondary to severe hypoalbuminemia,42 and skin xanthomata secondary to elevated serum 
cholesterol.58 Some patients experience malaise.42 Diabetic nephrotic syndrome patients have the classic symptoms 
of weight loss, polyuria, polydipsia, and polyphagia. Systemic lupus erythematosus patients most commonly present 
with arthritis and/or arthralgia (86%), butterfly rash (61%) and anemia (55%), followed by photosensitivity (48%), 
fever (43%), mouth ulcer (43%), headache (36%), the triad of fatigue, malaise, weakness (35%), and alopecia (35%).45 
Nephrotic syndrome associated with hepatic disease may produce non-specific symptoms of malaise or abdominal 
discomfort46. Although a pertinent medical history of alcoholism can assist the optometrist with a diagnosis of fatty 
liver disease, non-alcoholic patients are more difficult to diagnose, as most of these cases are detected incidentally 
through elevated liver enzymes on routine blood examination.46 Some patients may note an abdominal mass or a 
dorsocervical hump, which is associated with nonalcoholic steatohepatitis.47
DIFFERENTIAL DIAGNOSIS
Conjunctivochalasis and conjunctival lymphangiectasia can have features that mimic conjunctival chemosis. 
Conjunctivochalasis is a bilateral aging condition in which redundant conjunctival tissue prolapses forward past the 
eyelid margin, possibly obstructing the lower punctae.63 Redundant conjunctiva is usually located temporally and cen-
trally, a few millimeters below the lower limbus,64 while conjunctival chemosis extends to any quadrant. Mild cases of 
conjunctivochalasis are typically asymptomatic, while severe cases are more likely to result in punctal obstruction and 
tear film instability, with associated symptoms of foreign body sensation and epiphora. Such complications often result 
from mechanical disruption of the normal tear meniscus and impediment of nasolacrimal tear drainage.64 
Conjunctival lymphangiectasia is a rare acquired condition that is characterized by unilateral or bilateral dilatation 
of the conjunctival blood vessels, usually temporarily.65 This condition represents secondary lymphedema caused 
by disruption or obstruction of the conjunctival lymphatic flow.65 It appears as diffuse enlargement of the conjunc-
tival lymphatics (mimicking the appearance of chemosis) or focal dilatation of the lymphatics appearing as cysts. 
It is sometimes referred to as a “string of pearls” or “sausaging”,6 depending on the presence or absence of blood. 
Although the condition is most often diagnosed by appearance, recurrent cases can be biopsied.65 Anterior segment 
ocular coherence tomography (OCT) can be used by clinicians to forego biopsy and confirm the presence of dilated 
lymphatic vessels.66 Although the etiology is unknown, lymphangiectasia may be associated with previous trauma, 
other diseases (pterygium, neoplasm), or iatrogenic causes (ocular surgery, radiotherapy).65 Lymphangiectasia pa-
tients usually complain of epibulbar irregularities including injection, irritation, and epiphora.65 
EXTERNAL EXAMINATION
Suspicion of conjunctival chemosis as a result of a systemic condition requires physical evaluation of the patient, 
including the eyes and adnexa, head and neck, arms and legs, integument and hair, pulmonary system, and cardio-
vascular system. If a specific systemic association is suspected based upon a cursory examination, coordination of 
care with other specialties is important (Tables 4 and 5).2,6,18,30-58
Ocular Adnexa
Cases of conjunctival chemosis accompanied by eyelid retraction and edema, scleral show, and proptosis are usually 
indicative of hyperthyroidism. Proptosis combined with conjunctival chemosis should prompt investigations for or-
bital cellulitis and cavernous sinus disease, especially with deficits noted on extraocular muscle and pupillary testing. 
Cardiovascular and Pulmonary Systems 
Vitals (temperature, weight, pulse, blood pressure) and auscultation of the heart and lungs can provide signs (gallop, 
rales, wheezing, stridor) that can assist with determining a systemic etiology of chemosis. 
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Orbital cellulitis must be ruled out in patients who are febrile or have an oral temperature higher than 37.5°C (99.5°F). 
Orbital cellulitis may progress to develop signs of pain on eye movement, afferent pupillary defect, and periorbital edema. 
Unintentional weight loss suggests hyperthyroidism or malignancy, while weight gain suggests hypervolemia.41 
Tachycardia could suggest hyperthyroidism or heart failure, depending on the associated signs and symptoms.34,41 
Gallop heart beat (a 3-4 beat heart sound) is heard in up to 26% of patients with heart failure, in addition to rales 
(crackling on inhalation) in 25-45% of patients.41 
Hypotension (blood pressure less than 90/60 mmHg) and stridor (high-pitch whistling sound on inhalation) sug-
gest a possible diagnosis of drug or food hypersensitivity.33 
Dyspnea observed during external examination can be secondary to hypersensitivity reaction, hyperthyroidism, 
heart failure, superior vena cava syndrome, or various underlying hypervolemia etiologies.33,40,41,44 Assessing patients 
for Pemberton’s sign, i.e., facial congestion and cyanosis when a patient elevates both arms, is specific for latent 
superior vena cava syndrome.67 
Head and Neck
Assessing the patient’s head and neck is crucial to rule out lymphadenopathy and jugular vein distension, as lym-
phoma, thyroid, bronchogenic carcinoma, tuberculosis, systemic lupus erythematosus and syphilitic aortic aneu-
rysm can present with the former and cardiopulmonary disease can present with the latter – all of which can be 
associated with systemic causes of conjunctival chemosis. 
Integument and Hair
An evaluation of the patient’s integument for cutaneous manifestations such as alopecia (hair loss), rashes (changes 
in the skin’s appearance, including changes in texture and/or color), and edema can help the practitioner determine 
systemic etiologies of conjunctival chemosis (Table 6).18,31,33,42,45,48,49,51,52,68-70 
Hyperthyroidism, systemic lupus erythematosus, and secondary and tertiary syphilis can cause thin and brittle hair 
and/or hair loss (alopecia) of the scalp, eyebrow, and eyelashes.48,71 
Jaundice may be seen in various systemic conditions, including liver disease, tuberculosis, histoplasmosis, syphilis, Hodg-
kin’s and non-Hodgkin’s lymphoma, cardiorenal syndrome, and systemic lupus erythematosus.51,71 Skin xanthomata are 
usually seen in nephrotic syndrome patients with hypercholesterolemia.42 Patients with white nails, with or without 
white bands (Muercke’s lines), usually have underlying nephrotic syndrome.42 Skin rashes are more likely to be due to 
either a hypersensitivity reaction or systemic lupus erythematosus. Hypersensitivity reactions usually present with hives 
or urticaria, which appear as swollen, pale, red bumps or plaques. These reactions occur more often with foods than 
drugs (85.9% versus 66.7%)33. Systemic lupus erythematosus rashes present as a malar, “butterfly” facial rash (61%).45 
Unilaterality, type (pitting versus non-pitting), acuteness, and location of edema on external examination can assist 
with determining the etiology. Patients who sleep in a lateral decubitus position may have an ipsilateral presen-
tation of interstitial fluid accumulation, whether in a limb (arm, leg) or the conjunctiva, on the side they sleep.52 
Pitting edema, which is tissue indentation that remains after pressure is applied and released, may be observed in 
patients with heart failure, nephrotic syndrome, renal disease, and calcium channel blocker use.52 Non-pitting ede-
ma, which is tissue indentation that resolves after pressure is applied and released, may be observed in lymphoma, 
hyperthyroidism, and superior vena cava syndrome.52 
Acute-onset edema forming in the deeper dermal layers, termed angioedema, is usually due to hypersensitivity 
reactions. It can occur in any location (i.e., face, tongue, larynx, abdomen, arms, and legs), and presents more often 
with hypersensitivity reactions to foods (23.2%) than to drugs (18.1%).33 
Oral edema (lip-tongue-uvula edema) accompanied by skin itching and flushing is also usually due to hypersensitiv-
ity reactions, with a higher presence in foods than drugs hypersensitivities (90.9% versus 69.4%).33 
Periorbital edema usually presents in patients with carotid cavernous sinus thrombosis (80-100%), hypersensitiv-
ity/allergy, hyperthyroidism, and nephrotic syndrome.32 Nephrotic syndrome patients typically present with peri-
orbital edema that is most noticeable in the morning, end-of-day pitting edema of the legs and abdomen, and end-
of-day edema of the genitals.42 
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Non-pitting pre-tibial myxedema is seen in 1-5% of Grave’s disease patients.49,52 Although pre-malar and cheek 
swelling is seen in hyperthyroidism patients less than 50 years of age, its presentation is rare (1.84%).39 
Common edema noted in superior vena cava syndrome includes edema of the face or neck (82%) and upper ex-
tremities (68%), with the vast majority of these patients having bronchogenic carcinoma or the presence of an 
intravascular medical device.40 The facial swelling in these lung cancer patients is prominent in the morning and 
resolves in the evening. 
Generalized edema, anasarca, is seen in 35-70% of patients with hypervolemia.41 It is also seen in patients with hy-
persensitivity reactions, like the patient in this report who developed anasarca from amlodipine. 
Abdominal edema is usually secondary to nephrotic syndrome or liver disease.43 Hepatic disease can present with 
abdominal, facial and peripheral edema. 
Peripheral pitting edema of the arms and legs is usually due to hypervolemia (heart failure, nephrotic syndrome, 
liver disease).52 
TREATMENT AND MANAGEMENT
Treatment depends on the etiology (bacterial, allergic, viral, inflammatory) and includes surgical procedures, re-
moval of foreign bodies or eyelid cysts, and/or initiation of ophthalmic and oral antibiotics, anti-virals, anti-aller-
gics, anti-inflammatories, and various oral and intravenous medications.
Management of conjunctival chemosis is determined by the course of the disease (i.e., acute, subacute, chronic), the 
etiology, and the urgency of implementing the treatment plan. Ocular etiologies usually require non-urgent coordi-
nation of care, unless the chemosis is secondary to sight-threatening ocular disorders (penetrating ocular foreign 
bodies, acute glaucoma, orbital cellulitis, scleral rupture, or endophthalmitis). When there is suspicion of scleral 
rupture or alkaline chemical burn, ophthalmology should be consulted immediately. Orbital cellulitis cases require 
immediate referral to the emergency department for evaluation, orbital computerized tonography with and without 
contrast, intravenous antibiotics, and consideration of an infectious disease referral. When all ocular etiologies are 
excluded, it is crucial to correlate the slit lamp biomicroscopy findings with patient history, symptoms, and external 
examination findings, to prevent unwarranted and expensive testing in search of systemic etiologies with a low 
yield (Table 3).16,17,21,28 Chemosis that is suspected to be due to carotid cavernous sinus thrombosis, carotid cavernous 
sinus fistula, or acute decompensated heart failure requires immediate, same-day, referral to the emergency depart-
ment for evaluation, labs, and ancillary testing (Table 4).6,18,30-52 Non-emergent referrals to other specialties require 
coordination of care, so that the appropriate evaluation, labs, and ancillary testing can be completed to confirm or 
negate systemic conditions related to the eye-exam findings. 
CONCLUSION
Conjunctival chemosis is frequently encountered in a primary eye care setting and exhibits a wide range of associa-
tions and severity. Although most cases have an ocular etiology, determined by history and examination, cases with 
systemic etiologies require a thorough history, review of symptomatology, physical examination (assessing for jugular 
vein distension, pitting and non-pitting edema, lymphadenopathy, rash, jaundice, and alopecia), and medical evalua-
tion (pulse, BP, weight, heart and lung auscultation). In this report, two cases of conjunctival chemosis with different 
etiologies resulted in referrals to medical specialists to manage and treat their associated systemic conditions. l
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Table 1: Ocular etiologies of conjunctival chemosis and corresponding mechanism of action2,5-19 
Etiology Chemosis Mechanism of Action
Ocular trauma5,11
(including orbito-facial trauma)
Acute cases: 
Inflammatory reaction mediated by the release of 
histamine, serotonin, and bradykinin, accompanied 
by polymorphonuclear cell migration, which causes 
arteriole dilation, an increased pressure gradient between 
the arteriolar and venule capillaries, and extravasation of 
intravascular fluid and resultant vasodilatory edema5
Chronic cases: 
Blockage of 
lymphatic system 
from scarring or 
damage to the 
lymphatic drainage 
system19 
Ocular surgery7
Blockage of lymphatic system from scarring or damage to the lymphatic 
drainage system7
Anterior Segment 
Infection6
Conjunctivitis; 
Keratitis; Scleritis; 
Endophthalmitis
(Bacterial or Viral)6,14
Arteriole dilation, an increased pressure gradient between the arteriolar 
and venule capillaries, and extravasation of intravascular fluid and resultant 
vasodilatory edema18
Anterior Segment 
Inflammation6
Seasonal or perennial 
allergic conjunctivitis 
or keratitis6,12
Type I hypersensitivity (anaphylactoid) response, causing the release of 
histamine, serotonin, and bradykinin, accompanied by polymorphonuclear 
cell migration, which causes arteriole dilation, an increased pressure 
gradient between the arteriolar and venule capillaries, and extravasation of 
intravascular fluid and resultant vasodilatory edema2,18
Medicamentosa 
conjunctivitis or 
keratitis16,17
Type IV hypersensitivity (cell-mediated) response where CD4 T-helper cells 
recognize an antigen and cause the release of interleukins, cytokines, and 
enzymes, resulting in the extravasation of intravascular fluid and resultant 
vasodilatory edema2,18
Episcleritis; Scleritis;
Uveitis8
Arteriole dilation, an increased pressure gradient between the arteriolar 
and venule capillaries, and extravasation of intravascular fluid and resultant 
vasodilatory edema5
Acute Glaucoma23 Numerous mechanisms depending on the etiology
Orbital Disease9
Orbital infection 
(cellulitis)13
Sinus or upper respiratory infection spreading to the orbit and causing 
infection and inflammation of ocular tissues posterior to the orbital septum9
Orbital pseudotumor 
or malignancy11
Congestion or blockage of the lymphatic or venous system11
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Table 2: Chemosis inducing ocular and systemic medications16-18,21-27
Ocular Medications Systemic Medications
Topical anesthetics 
Proparacaine,17 
Tetracaine,17 
Lidocaine,17 
Benoxinate,17 
NSAIDS17
Birth control pills23
Cycloplegics Homatropine, Atropine17,18 Hormone replacement23
Glaucoma medications 
Apraclonidine,17 
Brimonidine,17 
Dorzolamide,17 
Prostaglandin analogues,17,18 
Dipivalyl epinephrine,18 
Echothiophate,18 Pilocarpine18
Anti-depressants23
Antivirals 
Idoxuridine,18 
Vidaribine,18 
Trifluoridine18
NSAID (ketoprofen; diclofenac)23,25
Aminoglycosides
Tobramycin,18 
Gentamycin,18 
Neomycin,18 
Vancomycin18
Imatinib mesylate (Gleevac)24
Artificial tears Lanolin-based artificial tears16
Hypertensive medications23,26,27
(Calcium channel blockers like amlodipine)Preservatives in 
ophthalmic medications 
Benzalkonium chloride; 
phenylmercuric nitrate17,18,22
Table 3: Ocular Signs of Medicamentosa16,17,21,28
Eyelid Conjunctiva Cornea
Punctal stenosis21,28 Follicular or papillary reaction21,28 Superficial punctate epitheliopathy21,28
Eyelid &/or periorbital swelling17,21
Bulbar injection17,21 Epithelial defect, ulceration16,21
Symblepharon &/or fornix shortening17,21 Ulceration16,28 
Scarring21,28 
Scarring16 
Pannus16
Neovascularization16
Perforation16
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Table 4a: Conjunctival chemosis with a systemic etiology of Hypersensitivity/Allergy
Association Presentation Symptomology Work-Up Coordination of Care Specialist
Food Acute Skin itching, flushing, eye, lip-tongue-
uvula edema (90.9%), Urticaria 
(86.9%), Cardiovascular symptoms 
such as syncope, hypotension, urinary 
incontinence, chest discomfort (31.3%), 
Hypotension (26.3%), Respiratory 
symptoms such as wheezing, stridor, 
hypoxemia (49.5%), Dyspnea (47.5%), 
Gastrointestinal symptoms such as 
crampy abdominal pain, vomiting, 
diarrhea (24.2%), Angioedema (23.2%), 
Pruritis (27.3%), and Neurological 
(20.2%)33
Skin prick test and 
serum allergen 
specific IgE 
tests (multiple 
allergosorbent 
test, MAST), CBC 
with differential, 
Serum total 
IgE, Eosinophil 
cationic protein 
(ECP), Liver 
panel33
Allergist or 
Emergency 
Department 
depending on the 
severity
Drug Skin itching, flushing, eye, lip-tongue-
uvula edema(69.4%), Urticaria(66.7%), 
Cardiovascular symptoms such 
as syncope, hypotension, urinary 
incontinence, chest discomfort(63.9%), 
Hypotension (41.7%), Respiratory 
symptoms such as wheezing, stridor, 
hypoxemia (45.8%), Dyspnea (45.8%), 
Gastrointestinal symptoms such as 
crampy abdominal pain, vomiting, 
diarrhea (25%), Angioedema (18.1%), 
Pruritis (23.6%), and Neurological 
(26.4%)33
Table 4b: Conjunctival chemosis with a systemic etiology of Cavernous Sinus Disease
Presentation Symptomology Work-Up Coordination of Care Specialist
Carotid cavernous 
sinus fistula
Subacute or Chronic Corkscrew arterialization 
of conjunctival veins 
(93%), Proptosis (84%), 
Decreased visual acuity 
(43%), Chemosis (42%), 
Ophthalmoparesis (52%: 73% 
abducens, 5% oculomotor, 
22%multiple), and Ocular 
bruit (28%)30
CT/CTA, or MRI/
MRA, or PCVD47
Emergency 
Department
Carotid cavernous 
sinus thrombosis
Acute Fever, proptosis, ptosis, CN 
III,IV or VI palsy (80-100%), 
Periorbital edema, headache, 
lethargy, altered sensorium 
(50-80%), Optic disc edema, 
and Venous engorgement32
CT/CTA or MRI/
MRA58
Emergency 
Department
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Table 4c: Conjunctival chemosis with a systemic etiology of Thyroid Disease (Hyperthyroidism1)
Presentation Symptomology Work-Up Coordination of Care Specialist
Subacute/ 
Chronic
Older patients (> 70y)34  
Tachycardia (71%), Fatigue (56%), Weight Loss (50%), 
Tremor (44%), Dyspnea (41%), Apathy (41%), Anorexia 
(32%), Nervousness (31%), Hyperactive reflexes (28%), 
Weakness (27%) Depression (24%), and Increased sweating 
(24%),34 Alopecia,31 Non-pitting pretibial myxedema31,52 
Skin prick test and 
serum allergen 
specific IgE 
tests (multiple 
allergosorbent 
test, MAST), CBC 
with differential, 
Serum total IgE, 
Eosinophil cationic 
protein (ECP), 
Liver panel33
Allergist or 
Emergency 
Department 
depending on the 
severity
Younger patients (< 50y)34 
Tachycardia (96%), Hyperactive reflexes (96%), Increased 
sweating (95%), Heat intolerance (92%), Fatigue (84%), 
Nervousness (84%), Tremor (84%), Polydipsia (67%), 
Weakness (61%), Increased appetite (57%), Dyspnea (56%), 
Weight Loss (51%), Diarrhea (43%), Anorexia (32%), Apathy 
(25%), and Depression (22%),34 Alopecia,31 Non-pitting pre-
tibial edema (1-5%)52
Thyroid orbitopathy(25-40%)35,36 
Eyelid retraction (90.7% at some point in the disease; 70% 
at time of diagnosis), Exophthalmos(62%), Restrictive 
extraocular myopathy (43%), Optic nerve dysfunction 
(6%), Full constellation of manifestations including 
eyelid retraction, exophthalmos, optic nerve dysfunction, 
extraocular muscle involvement (5%), Pain (30%), 
Lacrimation (20.8%), Diplopia (16.6% at initial presentation) 
, Photophobia (15.8%), Blurred vision (7.5%), Thyroid 
dermopathy (4%), and Acropachy(1%),37 Glabellar rhytids 
(82.5%),38 Premalar and cheek swelling(1.84%),39 Non-pitting 
pre-tibial edema (1-5%),49 Alopecia31
Table 4d: Conjunctival chemosis with a systemic etiology of Superior Vena Cava Syndrome
Presentation Symptomology Work-Up Coordination of Care Specialist
Malignant causes (60%)40
Lymphoma (8%)40
Bronchogenic Carcinoma (46%)40
• Small cell lung cancer(22%)40
• Non-small cell lung cancer (24%)40
Germ Cell Tumor (8%)40
• Metastatic prostate cancer (1.2%)40
• Thymic cancer (1.2%)40 
• Adenocarcinoma of unknown site(1.2%)40
Subacute/ 
Chronic
SVC generalized 
symptoms: Facial or 
Neck swelling (82%), 
Upper extremity 
swelling (68%), Dyspnea 
(66%), Cough (50%), 
and Dilated chest vein 
collaterals (38%),40 
Jaundice in lymphoma 
and syphillis51
CT or MRI 
chest at initial 
evaluation 
and tissue 
biopsy of 
masses52 
Oncologist
Benign Causes(40%)40
Intravascular device (71%), dialysis catheters 
(5%), pacemaker wire (1.2%), and Hickman 
catheter (1.2%)40
Fibrosing mediastinitis (8%)40
• Lymphoma, Histoplasmosis, Tuberculous,  
 and Syphilitic aortic aneurysms40
Other (3.6%)40
• Hematoma after aortic dissection repair;  
 Pseudo- tumor; Primary SVC thrombosis 40 
Subacute/ 
Chronic
Cardiologist
Infectious 
Disease; 
Cardiologist
Cardiologist
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Table 4e: Conjunctival chemosis with a systemic etiology of Hypervolemia
Presentation Symptomology Work-Up Coordination of Care Specialist
Cardiopulmonary Failure Subacute/ 
Chronic
All forms of Dyspnea, (87-
93%), Exertional dyspnea 
(86-97%), Orthopnea(10-59%), 
Paroxysmal dyspnea(13-39%), 
Dyspnea at rest(1-6%), Weight 
gain (5-15%), Jugular vein 
distension (5-54%), Abdominal 
jugular reflex (6%), Edema 
(35-70%), Gallop heart beat 
(1-26%), Rales (25-45%), and 
Ascites (3-17%).41 Jaundice if 
cardiorenal failure51
Hematocrit, protein 
level, albumin level, 
creatinine level, blood 
urea nitrogen level, 
plasma osmolality, and 
urine- specific gravity, 
Chest radiography, 
pulmonary artery 
catheterization, PRO 
BNP, CORS, TTE44
Cardiologist; 
Emergency 
Department
Nephrotic Syndrome
Idiopathic (80-90%)43,44
Primary Kidney Disease 
(10%)43,44
Membranous Nephropathy 
(30-35%), Focal Segmental 
Glomerulosclerosis 
(30-35%), Minimal 
Change Disease (15%), 
and Immunoglobulin A 
nephropathy (15%)43,44
Secondary disease 
(Underlying medical 
conditions) (10%)43,44
Diabetes Mellitus43,44
Immune disorders 
(i.e., systemic lupus 
erythematosus, etc.)43,44
Infectious conditions  
(i.e., HIV, hepatitis, etc.)43,44
Subacute/ 
Chronic
General symptoms for 
primary and secondary 
disease: Malaise, Weight gain, 
Foamy urine, Morning time 
periorbital edema, white 
nails with or without white 
bands (Muercke’s lines), skin 
xanthomata, and Alopecia42 
Significant evening peripheral 
pitting edema31,42 
Jaundice51
Urinalysis with protein 
to creatinine ratio, 
CBC and coagulation 
panel, renal function 
electrolytes, liver 
panel, glucose and 
HbA1C, focused 
testing for disorders 
by history and physical 
examination43 
ANA, Anti-dsDNA AB, 
anti-Sm AB, Anti-
phospholipid AB, anti-
RNA AB42,43
Nephrologist; 
Rheumatologist
Weight loss, polyuria, 
polydipsia, polyphagia
Systemic lupus erythematosus: 
Arthritis and/or arthralgia 
(86%), butterfly rash 
(61%), anemia (55%), 
photosensitivity(48%), fever 
(43%), mouth ulcer (43%), 
headache (36%), fatigue, 
malaise, and weakness (35%), 
and alopecia(35%).45  
Non-pitting, generalized 
edema,.18 
Dependent pitting edema at the 
end of the day18
Renal Disease Subacute/ 
Chronic
Malaise or abdominal 
discomfort,46 abdominal mass,46 
or a dorsocervical hump,47 
jaundice,51 weight gain,41 Facial 
edema, Abdominal edema, 
Peripheral pitting edema52 
Renal Panel (to include 
AST, ALT, AST to 
ALT ratio, Alkaline 
phosphatase and 
γ-glutamyltransferase, 
bilirubin, albumin, 
GFR), and Hepatic 
Ultrasound or MRI46 
Hepatologist
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Table 5: Conjunctival chemosis mechanism of action of systemic disorders2,6,18,33,40,42,49,53-58
Etiology Systemic Mechanism of Action
Cavernous Sinus 
Disease 
Carotid cavernous sinus fistula
Impaired venous drainage secondary to abnormal communication 
between the internal carotid artery and cavernous sinus, or the 
meningeal branches of the internal carotid artery or external 
carotid artery and cavernous sinus57
Carotid cavernous sinus thrombosis
Impaired venous drainage secondary to nasal, sinus, ear, or dental 
infection32,58 
Hypersensitivity/ Allergy
Allergic reaction to animal dander, pollen, food, medication, venom 
or drugs, mediated by the release of histamine, serotonin, and 
bradykinin, accompanied by polymorphonuclear cell migration, 
which causes arteriole dilation, an increased pressure gradient 
between the arteriolar and venule capillaries, and extravasation of 
intravascular fluid and resultant vasodilatory edema2,18,33
Hyperthyroidism
Fluid accumulation of glycosaminoglycans in connective tissue, 
resulting in edema and inflammation of the extraocular muscles, 
orbital connective tissue and fat, increased orbital volume, and 
decreased venous and lymphatic drainage49,53
Superior Vena 
Cava Syndrome
Lymphoma
Large lymph node compressing the superior vena cava causing 
decreased venous drainage40
Bronchogenic. Carcinoma (Small 
and Non-Small Lung Cancer)
Mass compressing the superior vena cava causing decreased 
venous drainage40
Germ Cell Tumor (Prostate, 
Thymic, Adenocarcinoma)
Mass compressing the superior vena cava causing decreased 
venous drainage40
Intravascular devices 
Device compressing the superior vena cava causing decreased 
venous drainage40
Fibrosing mediastinitis (Lymphoma; 
Histoplasmosis; Tuberculosis; 
Syphilic aortic aneurysm)
Fibrous tissue scarring compressing the superior vena cava causing 
decreased venous drainage40
Other (Hematoma after aortic 
dissection repair; Pseudo- tumor; 
Primary SVC thrombosis)
Compression of the superior vena cava causing decreased venous 
drainage40
Fluid Overload 
Syndrome 
Cardiopulmonary Failure
Dilatation of the ocular vascular system caused by hypoxia, 
hypercapnia, which impedes thoracic venous return, by positive 
pressure ventilation, inducing jugular venous distention and fluid 
overload56
Nephrotic 
Syndrome
Primary Kidney 
Disease
Low blood protein (hypoproteinemia), causing decreased colloidal 
osmotic pressure, which alters the osmotic gradient between the 
plasma and interstitial fluid, causing salt and water retention, and fluid 
egression into extracellular spaces6,42,54
Patients with systemic signs: Low blood protein (hypoproteinemia), 
causing decreased colloidal osmotic pressure, which alters the osmotic 
gradient between the plasma and interstitial fluid, causing fluid 
egression into extracellular spaces6,54
Patients without systemic signs: Localized edema from immune 
complexes, causing increased polymorphonuclear cell presence, and 
increased edema and inflammation54,55
Secondary 
Kidney Disease, 
specifically 
Systemic Lupus 
Erythematosus
Liver Disease
Low blood protein (hypoalbuminemia) causing decreased colloidal 
osmotic pressure, an increase in oncotic pressure, and fluid egression 
into the ocular soft tissues6
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Table 6: Cutaneous presentations in systemic diseases that may present with conjunctival chemosis18,31,33,42,45,48,49,51,52,68-70
Systemic Condition
Cutaneous Presentation
Rash
Alopecia  
(Yes Or No)
Jaundice 
(Yes Or No)
Edema
(None; Pitting;  
Non-Pitting) 
Hypersensitivity/
Allergy
Drug-induced Hives; Urticaria (swollen, 
pale, red bumps or 
plaques) 66.7%33 
No No None
Food-induced Hives; Urticaria (swollen, 
pale, red bumps or 
plaques); 86.9%33
No No None
Hyperthyroidism/Grave’s Disease Pretibial myxedema 
presenting with 
asymptomatic warm, 
moist, soft, velvety, and 
smooth erythema to the 
severe elephantiasic 
form (1-5%)49,52 
Yes10 No Non-pitting pretibial 
myxedema31,52 
Superior Vena 
Cava Syndrome
Tumor, Lymph 
node, lymphatic 
vessel damage, 
radiotherapy51
No No Yes, if 
lymphoma51
Non-Pitting52
Syphilis 
(presenting in 
extragenital 
areas)
Primary Chancre without 
basal induration with 
edges rising above the 
surrounding surface (2%)69
Yes Yes51 None
Secondary Macular, popular, 
papulosquamous, 
pustular lesion (4.76%-
59%), depending on 
location, with higher 
presentation on soles, 
trunk, arms, palms, legs.70
Tertiary Firm necrotic centered 
gummi lesions (15%)48
Pitting, if patient has 
heart failure52
Fluid Overload 
Syndrome
Congestive 
Heart Failure
No No Yes, if 
cardiorenal 
failure51
Pitting51
Nephrotic 
Syndrome
Primary Kidney disease White nails 
with or without 
white bands 
(Muercke’s 
lines), and skin 
xanthomata42
Yes48 Yes51 Non-
pitting 
generalized 
edema18,52 
or 
dependent 
pitting 
edema at 
the end of 
the day18
Systemic Lupus 
Erythematosus
White nails 
with or without 
white bands 
(Muercke’s 
lines), and skin 
xanthomata42
Any form of 
rash (>80%)68
Butterfly rash 
(61%)45
Renal Disease No Yes51 Pitting52
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